27121486|t|Relationship between XspI Site Polymorphisms of LDL-R Gene and Serum IL-2 and IL-10 in Patients with Hypercholesterolemia
27121486|a|Relationship has been identified in sporadic reports between polymorphisms and hypercholesterolemia. However, the relationship between inflammatory cytokines and polymorphism of low-density lipoprotein receptor (LDL-R) gene in hypercholesterolemia is unclear. This study aimed to explore the relationship and significance between polymorphisms of LDL-R gene and serum Interleukin-2 (IL-2), IL-10 in patients with hypercholesterolemia. PCR-RFLP and direct DNA sequencing assay were employed to determine polymorphism of LDL-R gene in 900 patients with hypercholesterolemia and 400 healthy cases. ELISA was applied to assay serum concentration of IL-2 and IL-10. Blood lipid indexes were tested in all cases. Compared with the healthy controls, level of IL-2 increased significantly, while IL-10 decreased significantly (P < 0.05). Correlation analysis showed that IL-2 was positively correlated with total cholesterol (TC), LDL-c, and genotype (r = 0.542, 0.410, 0.598, P < 0.05) and negatively correlated with HDL-c (r = -0.352, P < 0.05). Negative relationship also was found between TC, LDL-c, genotype, and IL-10 (r = -0.452, -0.390, -0.613, P < 0.05), and positive correlation between HDL-c and IL-10 (r = 0.398, P < 0.05). Multiple linear regression showed that genotypes and TC were independent factors affecting the levels of IL-2 and IL-10 (P < 0.05). IL-2 and IL-10 were related to gene polymorphisms of LDL-R, which might be involved in the development and progress of hypercholesterolemia.
27121486	0	12	Relationship	T080	C0439849
27121486	21	25	XspI	T116,T126	C0752931
27121486	26	44	Site Polymorphisms	T049	C1709929
27121486	48	58	LDL-R Gene	T028	C1366529
27121486	63	73	Serum IL-2	T116,T129	C0021756
27121486	78	83	IL-10	T116,T129	C0085295
27121486	87	95	Patients	T101	C0030705
27121486	101	121	Hypercholesterolemia	T047	C0020443
27121486	122	134	Relationship	T080	C0439849
27121486	144	154	identified	T080	C0205396
27121486	158	174	sporadic reports	T033	C0243095
27121486	183	196	polymorphisms	T045	C0678951
27121486	201	221	hypercholesterolemia	T047	C0020443
27121486	236	248	relationship	T080	C0439849
27121486	257	269	inflammatory	T169	C0333348
27121486	270	279	cytokines	T116,T129	C0079189
27121486	284	296	polymorphism	T045	C0678951
27121486	300	345	low-density lipoprotein receptor (LDL-R) gene	T028	C1366529
27121486	349	369	hypercholesterolemia	T047	C0020443
27121486	373	380	unclear	T033	C3845108
27121486	387	392	study	T062	C2603343
27121486	393	398	aimed	T078	C1947946
27121486	414	426	relationship	T080	C0439849
27121486	431	443	significance	T078	C0750502
27121486	452	465	polymorphisms	T045	C0678951
27121486	469	479	LDL-R gene	T028	C1366529
27121486	484	503	serum Interleukin-2	T116,T129	C0021756
27121486	505	509	IL-2	T116,T129	C0021756
27121486	512	517	IL-10	T116,T129	C0085295
27121486	521	529	patients	T101	C0030705
27121486	535	555	hypercholesterolemia	T047	C0020443
27121486	557	565	PCR-RFLP	T059	C0200930
27121486	570	597	direct DNA sequencing assay	T059,T063	C0917792
27121486	603	611	employed	T033	C0557351
27121486	625	637	polymorphism	T045	C0678951
27121486	641	651	LDL-R gene	T028	C1366529
27121486	659	667	patients	T101	C0030705
27121486	673	693	hypercholesterolemia	T047	C0020443
27121486	702	709	healthy	T080	C3898900
27121486	710	715	cases	T169	C0868928
27121486	717	722	ELISA	T059	C0014441
27121486	727	734	applied	T169	C4048755
27121486	738	763	assay serum concentration	T081	C0683149
27121486	767	771	IL-2	T116,T129	C0021756
27121486	776	781	IL-10	T116,T129	C0085295
27121486	783	794	Blood lipid	T109	C0596192
27121486	795	802	indexes	T170	C0600653
27121486	808	814	tested	T169	C0039593
27121486	822	827	cases	T169	C0868928
27121486	829	837	Compared	T052	C1707455
27121486	847	863	healthy controls	T080	C2986479
27121486	865	870	level	T080	C0441889
27121486	874	878	IL-2	T116,T129	C0021756
27121486	879	888	increased	T081	C0205217
27121486	889	902	significantly	T078	C0750502
27121486	910	915	IL-10	T116,T129	C0085295
27121486	916	925	decreased	T081	C0205216
27121486	926	939	significantly	T078	C0750502
27121486	952	972	Correlation analysis	T062,T170	C0010101
27121486	985	989	IL-2	T116,T129	C0021756
27121486	994	1004	positively	T033	C3843166
27121486	1005	1015	correlated	T080	C1707520
27121486	1021	1038	total cholesterol	T109	C0543421
27121486	1040	1042	TC	T109	C0543421
27121486	1045	1050	LDL-c	T109,T123	C0023824
27121486	1056	1064	genotype	T032	C0017431
27121486	1105	1115	negatively	T033	C0243095
27121486	1116	1126	correlated	T080	C1707520
27121486	1132	1137	HDL-c	T109,T123	C0023822
27121486	1162	1170	Negative	T033	C0205160
27121486	1171	1183	relationship	T080	C0439849
27121486	1207	1209	TC	T109	C0543421
27121486	1211	1216	LDL-c	T109,T123	C0023824
27121486	1218	1226	genotype	T032	C0017431
27121486	1232	1237	IL-10	T116,T129	C0085295
27121486	1282	1290	positive	T033	C1446409
27121486	1291	1302	correlation	T080	C1707520
27121486	1311	1316	HDL-c	T109,T123	C0023822
27121486	1321	1326	IL-10	T116,T129	C0085295
27121486	1350	1376	Multiple linear regression	T081	C0023733
27121486	1389	1398	genotypes	T032	C0017431
27121486	1403	1405	TC	T109	C0543421
27121486	1411	1422	independent	T078	C0085862
27121486	1423	1430	factors	T169	C1521761
27121486	1431	1440	affecting	T169	C0392760
27121486	1445	1459	levels of IL-2	T059	C0022885
27121486	1455	1459	IL-2	T116,T129	C0021756
27121486	1464	1469	IL-10	T059	C0022885
27121486	1482	1486	IL-2	T116,T129	C0021756
27121486	1491	1496	IL-10	T116,T129	C0085295
27121486	1502	1509	related	T080	C0439849
27121486	1513	1531	gene polymorphisms	T045	C0678951
27121486	1535	1540	LDL-R	T028	C1366529
27121486	1557	1565	involved	T169	C1314939
27121486	1573	1584	development	T169	C1527148
27121486	1589	1597	progress	T169	C1280477
27121486	1601	1621	hypercholesterolemia	T047	C0020443